Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent W Hunter

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Clinical & Experimental Metastasis|September 1, 2005
Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behaviorAlexander D Borowsky, Ruria Namba, Lawrence J T Young, et al.
Molecular Cell|December 4, 2025
NAT10 promotes cancer metastasis by modulating p300/CBP activity through chromatin-associated tRNARuhul Amin, Ngoc-Han Ha, Tinghu Qiu, et al.
Journal of Proteome Research|July 11, 2006
Parallel analysis of transcript and translation profiles: identification of metastasis-related signal pathways differentially regulated by drug and genetic modificationsHaiyan Yang, Li-Rong Yu, Ming Yi, et al.
Molecular Cancer Therapeutics|December 29, 2011
DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancerMin Chen, Daniel Shabashvili, Akbar Nawab, et al.
Plos Genetics|June 21, 2022
Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competenceVanesa C Sanchez, Howard H Yang, Alayna Craig-Lucas, et al.
Oncotarget|April 22, 2017
Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasisYuan Yang, Howard H Yang, Ying Hu, et al.
Plos Genetics|December 18, 2007
Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasisNigel P S Crawford, Xiaolan Qian, Argyrios Ziogas, et al.
Cancer Research|February 17, 2023
Dysregulation of Mitochondrial Translation Caused by CBFB Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast CancerNavdeep Malik, Young-Im Kim, Hualong Yan, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2024
Loss of NAT10 disrupts enhancer organization via p300 mislocalization and suppresses transcription of genes necessary for metastasis progressionRuhul Amin, Ngoc-Han Ha, Tinghu Qiu, et al.
Molecular Cell|December 19, 2020
In Vivo Evidence for Serine Biosynthesis-Defined Sensitivity of Lung Metastasis, but Not of Primary Breast Tumors, to mTORC1 InhibitionGianmarco Rinaldi, Erica Pranzini, Joke Van Elsen, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Clinical & Experimental Metastasis|September 1, 2005
Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behaviorAlexander D Borowsky, Ruria Namba, Lawrence J T Young, et al.
Molecular Cell|December 4, 2025
NAT10 promotes cancer metastasis by modulating p300/CBP activity through chromatin-associated tRNARuhul Amin, Ngoc-Han Ha, Tinghu Qiu, et al.
Journal of Proteome Research|July 11, 2006
Parallel analysis of transcript and translation profiles: identification of metastasis-related signal pathways differentially regulated by drug and genetic modificationsHaiyan Yang, Li-Rong Yu, Ming Yi, et al.
Molecular Cancer Therapeutics|December 29, 2011
DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancerMin Chen, Daniel Shabashvili, Akbar Nawab, et al.
Plos Genetics|June 21, 2022
Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competenceVanesa C Sanchez, Howard H Yang, Alayna Craig-Lucas, et al.
Oncotarget|April 22, 2017
Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasisYuan Yang, Howard H Yang, Ying Hu, et al.
Plos Genetics|December 18, 2007
Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasisNigel P S Crawford, Xiaolan Qian, Argyrios Ziogas, et al.
Cancer Research|February 17, 2023
Dysregulation of Mitochondrial Translation Caused by CBFB Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast CancerNavdeep Malik, Young-Im Kim, Hualong Yan, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2024
Loss of NAT10 disrupts enhancer organization via p300 mislocalization and suppresses transcription of genes necessary for metastasis progressionRuhul Amin, Ngoc-Han Ha, Tinghu Qiu, et al.
Molecular Cell|December 19, 2020
In Vivo Evidence for Serine Biosynthesis-Defined Sensitivity of Lung Metastasis, but Not of Primary Breast Tumors, to mTORC1 InhibitionGianmarco Rinaldi, Erica Pranzini, Joke Van Elsen, et al.
Pageof 8